Winkler J K, Suttle D P
Division of Biochemical and Clinical Pharmacology, St. Jude Children's Research Hospital, Memphis, TN 38101.
Am J Hum Genet. 1988 Jul;43(1):86-94.
Hereditary orotic aciduria is an autosomal recessive disease in which there is a severe deficiency in the activity of the de novo pyrimidine pathway enzyme uridine 5'-monophosphate (UMP) synthase. UMP synthase is a bifunctional enzyme containing the two activities orotate phosphoribosyltransferase and orotidine 5'-monophosphate decarboxylase, which catalyze the two-step conversion of orotic acid to UMP. Cell lines from three orotic aciduria patients have been characterized for UMP synthase gene and mRNA content. Restriction-enzyme analysis of DNA from the deficient cells revealed no changes in the gene structure compared with normal cell DNA structure. The amount of UMP synthase mRNA was not decreased, nor was there a detectable difference in the size of the UMP synthase mRNA in the deficient cells. Analysis of the mRNA by hybridization with a nearly full-length UMP synthase cDNA followed by S1 nuclease digestion showed no alteration in the mRNA structure. The UMP synthase activity of the deficient cells ranges from 2% to 7% of the normal cell level. The activity can be significantly increased by growing the deficient cells in barbituric acid. Our data indicate that UMP synthase gene transcription in the orotic aciduria cells produces the expected amount of a stable, correctly processed mRNA. The mRNA appears to code for a mutant enzyme that has reduced stability or altered kinetic properties.
遗传性乳清酸尿症是一种常染色体隐性疾病,其中从头嘧啶途径酶尿苷5'-单磷酸(UMP)合酶的活性严重缺乏。UMP合酶是一种双功能酶,具有乳清酸磷酸核糖基转移酶和乳清苷5'-单磷酸脱羧酶两种活性,它们催化乳清酸两步转化为UMP。对三名乳清酸尿症患者的细胞系进行了UMP合酶基因和mRNA含量的鉴定。对缺陷细胞的DNA进行限制性酶切分析显示,与正常细胞DNA结构相比,基因结构没有变化。UMP合酶mRNA的量没有减少,缺陷细胞中UMP合酶mRNA的大小也没有可检测到的差异。用几乎全长的UMP合酶cDNA杂交分析mRNA,然后用S1核酸酶消化,结果显示mRNA结构没有改变。缺陷细胞的UMP合酶活性为正常细胞水平的2%至7%。通过在巴比妥酸中培养缺陷细胞,活性可显著增加。我们的数据表明,乳清酸尿症细胞中的UMP合酶基因转录产生了预期量的稳定、正确加工的mRNA。该mRNA似乎编码一种稳定性降低或动力学特性改变的突变酶。